Company: SXTPW
Filing Date: 2025-08-27
Form Type: DEF 14A
Source: 0001213900-25-080878
Chunk: 14

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-27
Form: DEF 14A
Chunk 14
---
 announce the final voting results of the Annual Meeting on a Current
Report on Form 8-K filed with the SEC within four business days after the Annual Meeting.

Q: Do any directors or officers of the Company have a personal interest in the matter to be acted upon at the Annual Meeting?

A:Except for those directors who are nominated
for election at the Annual Meeting, no officer or director has any substantial interest, direct or indirect, by security holdings or otherwise
in all proposals voted on in Proposal 2, Proposal 3 and Proposal 4 that is not shared by all other stockholders.

Q: What if other matters are presented for consideration at the Annual Meeting?

A:The Company knows of no other matters
to be submitted to the stockholders at the Annual Meeting, other than those described herein. If other matters do arise, the Board has
made no recommendation as to how the proxies will vote on such other matters. If any other matters properly come before the stockholders
at the Annual Meeting, it is the intention of the persons named on the proxy card as proxies to vote the shares represented thereby on
such matters in their discretion and in accordance with their best judgment.

Q: Whom do I call if I have questions?

A:If you have any questions, need additional
material, or need assistance in voting your shares, please feel free to contact InvestorComLLC at (877) 972-0090.

<div align='center'>7

MATTERS REQUIRING STOCKHOLDER ACTION

PROPOSAL 1

ELECTION OF DIRECTORS (Item 1 on the Proxy Card)</div>

Nominees

There are five (5) nominees recommended by the
Nominating and Corporate Governance Committee of the Board (the “Nominating and Corporate Governance Committee”) for election
this year to hold office until the 2025 Annual Meeting of the Stockholders and until their respective successors are elected and qualified.
Our Board has nominated: (i) Geoffrey Dow; (ii) Charles Allen; (iii) Cheryl Xu; (vi) Stephen Toovey; and (v) Paul Field and our management
has no reason to believe that any nominee will be unable to serve. Their biographies are provided at pages 9 to 10. The biographies of
each of the nominees contains information regarding the person’s service as a director, business experience, public-company director
positions held currently or at any time during the last five years, information regarding involvement in certain legal or administrative